Rekombinanter LMO2 Antikörper (AA 23-140)
Kurzübersicht für Rekombinanter LMO2 Antikörper (AA 23-140) (ABIN7872476)
Target
Alle LMO2 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 23-140
-
Verwendungszweck
- Recombinant LMO2 Antibody / Rhombotin 2
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A portion of amino acids 23-140 was used as the immunogen for the recombinant LMO2 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant LMO2 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant LMO2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- LMO2 (LIM Domain Only 2 (Rhombotin-Like 1) (LMO2))
-
Andere Bezeichnung
- LMO2
-
Hintergrund
- The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. It has a particular function in normal and lymphatic endothelial cells involving the regulation of angiogenesis and lymph-angiogenesis. Immunohistochemical studies have also demonstrated expression of LMO2 in both normal germinal center B-cells and germinal center-derived B-cell lymphomas, including follicular lymphoma and diffuse large B-cell lymphoma.The use of anti-LMO2 is valuable as a tool in the identification of lymphomas of B-cell origin.LMO2 is useful in differentiating follicular lymphoma (LMO2+) from nodal marginal zone lymphoma (LM02-). It also is positive in Hodgkin s and Burkitt s lymphomas.
-
UniProt
- P25791
-
Pathways
- Chromatin Binding
Target
-